Medtech companies face a significant challenge in having to innovate with new products while maintaining the service improvements required for complex, carefully engineered technologies already on the market – all in the midst of an unprecedented global pandemic. Nevertheless, the landscape for the industry’s traditionally big-ticket investments in innovation is expanding, with fresh opportunities to serve patients and providers with novel tools like robotics, blockchain, digital therapeutics, machine learning and other AI-related methodologies.

To mark the Prix Galien USA’s upcoming October 25 “Week of Discovery and Celebration on the Frontiers of Medical Innovation,” distinguished members of the USA Galien Awards Committee will chair three Webinars highlighting each of the 18 nominee technologies they have selected in the MedTech category. These virtual expert panelist exchanges will offer the opportunity for participants to review the current state of innovation in MedTech, covering key aspects of clinical progress and differentiation; the ways that patient care is now being delivered outside the traditional delivery setting; and the next wave of promising technologies, including their transformative – and potentially disruptive – effect on health care productivity and outcomes worldwide.